Unlocking the Potential of Bone Densitometry: A Reliable Diagnostic Tool
According to market research report, "Bone Densitometer Market by Type (DEXA, Peripheral), Application (Osteopenia & Osteoporosis, Cystic Fibrosis, CKD, Body Composition Measurement, Rheumatoid Arthritis), End User (Hospitals & Specialty Clinics, Diagnostic Centres) - Global Forecast to 2027", is projected to reach USD 378 million by 2027 from USD 299 million in 2022, at a CAGR of 4.7% during the forecast period.
Factors such as the increasing prevalence of osteoporosis and the growing geriatric population are expected to drive the growth of this market during the forecast period. However, the high cost of bone densitometers is expected to restrain the growth of this market during the forecast period.
In the last few decades, the geriatric population has increased significantly across the globe. Globally, the population aged 65 and over is growing faster than all other age groups.
According to data from World Population Prospects, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over. In 2018, for the first time in history, persons aged 65 or above outnumbered children under five years of age globally. The number of persons aged 80 years or over is projected to triple, from 143 million in 2019 to 426 million in 2050.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15369222
By Application, the Osteoporosis & Osteopenia Diagnosis segment is expected to account for the largest share of the Bone Densitometer market
The osteoporosis & osteopenia diagnosis accounted for the largest share of the global bone densitometer market in 2021. The large share of this segment can be attributed to the growing geriatric population and the subsequent increase in the prevalence of osteoporosis, the increasing risk of osteoporosis in menopausal women, and the growing global incidence of fragility fractures.
By End User, the Hospitals & Specialty Clinics segment is expected to account for the largest share of the Bone Densitometer market
The hospitals & specialty clinics segment accounted for the largest share of the global bone densitometer market in 2021. The large share of this segment can be attributed to the higher preference of patients for hospital-based treatment of diseases such as cystic fibrosis, chronic kidney disease, and osteoporosis.
North America dominated this market with the largest share in 2021
In 2021, North America dominated this market with the largest share. This can be attributed to the high consumer awareness, rising healthcare expenditure, the increasing prevalence of osteoporosis, and the presence of key market players in the region.
Some of the prominent players operating in the global bone densitometers market are GE Healthcare (US), Hologic, Inc. (US), OSI Systems, Inc. (US), Diagnostic Medical Systems Group (France), Swissray Global Healthcare Holding, Ltd. (Taiwan), BeamMed, Ltd. (Israel), Echolight S.P.A (Italy), Scanflex Healthcare AB (Sweden), Medonica Co., Ltd. (South Korea), Eurotec Systems S.r.l (Italy), AMPall Co., Ltd. (South Korea), L’acn L’accessorio Nucleare S.R.L (Italy), Shenzhen XRAY Electric Co., Ltd. (China), YOZMA BMTech Co., Ltd. (South Korea), Nanoomtech Co., Ltd. (South Korea), Osteosys Corporation (South Korea), FURUNO Electric Co., Ltd. (Japan), Xianyang Kanrota Digital Ultrasound System, Co., Ltd. (China), XinGaoYi Co., Ltd. (China), Anjue Medical Equipment (China), Guangzhou Medsinglong Medical Equipment Co., Ltd. (China), Trivitron Healthcare (India), OsCare Medical Oy (Finland), CyberLogic, Inc. (US), and Nanjing Kejin Industrial Co., Ltd. (China).
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian